A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction
Hypertension Research, February 11, 2013
Takagi H et al. - The authors performed an updated meta-analysis of telmisartan vs. valsartan therapy for the reduction of BP in hypertensive patients. Telmisartan therapy appears to reduce BP more than valsartan therapy in patients with hypertension. Methods The authors performed an updated meta-analysis of telmisartan vs. valsartan therapy for the reduction of BP in hypertensive patients. Pooled analysis suggested significant differences in BP reductions among the ...
Diovan information Center
Novartis, May 2, 2013
There has been recent media coverage on the Kyoto Heart1 and Jikei Heart2 trials, which were Japanese post registration investigator initiated valsartan trials. Investigator initiated trials are conceived, designed and conducted by independent steering committees of physicians. There have been allegations of an undisclosed conflict of interest related to the Kyoto Heart and Jikei Heart trials. The conflict of interest allegations include a Novartis employee who was allegedly involved in the ...